Michael Hinds
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Acute Lymphoblastic Leukemia research, Lung Cancer Research Studies, Bacterial Genetics and Biotechnology, DNA Repair Mechanisms
Most-Cited Works
- → Characterization of an Amsacrine-resistant Line of Human Leukemia Cells(1989)179 cited
- Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.(1991)
- → Properties of R1162, a broad-host-range, high-copy-number plasmid(1982)65 cited
- → HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II(1990)58 cited
- → Multiple mechanisms for expression of incompatibility by broad-host-range plasmid RK2(1982)48 cited
- → Broad-host-range IncP-4 plasmid R1162: effects of deletions and insertions on plasmid maintenance and host range(1982)45 cited
- → Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions(1991)38 cited
- Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.(1990)
- Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.(1988)
- Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.(1992)